Company Analysis
Sign in

Shattuck Labs, Inc. (STTK)

Nasdaq: STTK · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2016
Full chart Alerts Compare
Grade4.8
◀ Past 4.9● Present 5.3▶ Future 4.4
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

21 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Shattuck Labs, Inc.’s names, not what it holds today.

Patents granted
21
21 utility, 1976 to Dec 31, 2025
Granted in 2025
3
Against 3 in 2024 and 3 in 2023
Applications published
52
6 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology11
Pharmaceuticals8
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Shattuck Labs, Inc. its own name
named as the applicant on its applications, in US
0 granted
51 published
Shattuck Labs, Inc. its own name
US, as the owner printed on each patent
21 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 9, 202512,492,236Fusion proteins for the treatment of cardiometabolic diseasesPharmaceuticalsShattuck Labs, Inc.
Nov 4, 202512,460,010Antibodies that bind TNFRSF25PharmaceuticalsShattuck Labs, Inc.
Jun 3, 202512,319,742Antibodies that bind TNFRSF25PharmaceuticalsShattuck Labs, Inc.
Nov 19, 202412,145,975Fusion proteins for the treatment of cardiometabolic diseasesPharmaceuticalsShattuck Labs, Inc.
Aug 27, 202412,071,465Methods of making and using extracellular domain-based chimeric proteinsPharmaceuticalsShattuck Labs, Inc.
Feb 13, 202411,896,618FLT3L-based chimeric proteinsBiotechnologyShattuck Labs, Inc.
Dec 5, 202311,834,488VSIG8-based chimeric proteinsBiotechnologyShattuck Labs, Inc.
Oct 10, 202311,780,897Heterodimeric proteins and uses thereofBiotechnologyShattuck Labs, Inc.
May 9, 202311,643,447Heterodimeric proteins for modulating gamma delta T cellsBiotechnologyShattuck Labs, Inc.
May 17, 202211,332,509Methods of making and using extracellular domain-based chimeric proteinsPharmaceuticalsShattuck Labs, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 13, 20252025/0345406CHIMERIC PROTEINS IN AUTOIMMUNITYBiotechnologyShattuck Labs, Inc.
Oct 16, 20252025/0320268CLINICAL DOSING OF SIRP1A CHIMERIC PROTEINBiotechnologyShattuck Labs, Inc.
Sep 4, 20252025/0277049ANTIBODIES THAT BIND TNFRSF25PharmaceuticalsShattuck Labs, Inc. · patent 12,460,010 granted from it
Jul 10, 20252025/0223313METHODS OF CONTAMINANT REMOVAL FROM PROTEIN ISOLATESBiotechnologyShattuck Labs, Inc.
May 8, 20252025/0145681FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASESPharmaceuticalsShattuck Labs, Inc.
Feb 27, 20252025/0066446FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASESPharmaceuticalsShattuck Labs, Inc.
Nov 7, 20242024/0368242METHODS OF MAKING AND USING EXTRACELLULAR DOMAIN-BASED CHIMERIC PROTEINSPharmaceuticalsShattuck Labs, Inc.
Sep 12, 20242024/0299492COMBINATION THERAPIES WITH SIRP ALPHA-BASED CHIMERIC PROTEINSPharmaceuticalsShattuck Labs, Inc.
Aug 8, 20242024/0262881FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASESPharmaceuticalsShattuck Labs, Inc. · patent 12,492,236 granted from it
Jul 4, 20242024/0218040FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASESPharmaceuticalsShattuck Labs, Inc. · patent 12,145,975 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 10 · Biotechnology 7.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton STTK · research, not advice